July 31, 2024 review Drug repurposing for glomerular diseases: an underutilized resource Nature Reviews Nephrology DOI: 10.1038/s41581-024-00864-8 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 15 References 8 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis 2020 New England Journal of Medicine article Medicine Systemic Lupus Erythematosus Research Open access cited by 12 patents 1,041 citations Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial 2021 The Lancet article Medicine Systemic Lupus Erythematosus Research cited by 4 patents 631 citations Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study 2022 Journal of the American Society of Nephrology article Medicine Vasculitis and related conditions Open access cited by 2 patents 70 citations Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies 2022 American Journal of Nephrology article Immunology and Microbiology Complement system in diseases Open access 70 citations A Core Outcome Set for Trials in Glomerular Disease 2021 Clinical Journal of the American Society of Nephrology article Social Sciences Delphi Technique in Research Open access 16 citations A Core Outcome Set for Trials in Glomerular Disease : A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops 2022 RWTH Publications (RWTH Aachen) article Social Sciences Delphi Technique in Research 11 citations WCN24-912 IMAGINATION: A GLOBAL PHASE 3 TRIAL OF RO7434656, AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF COMPLEMENT FACTOR B, IN IGA NEPHROPATHY 2024 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access 9 citations 8 results